# A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis

> **NCT00245479** · PHASE4 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 802 (actual)

## Conditions studied

- Nocturnal Enuresis

## Interventions

- **DRUG:** Primary nocturnal enuresis

## Key facts

- **NCT ID:** NCT00245479
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2005-09
- **Final completion:** 2006-11
- **Target enrollment:** 802 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245479, "A Study of Oral Desmopressin in Previously Untreated Children Aged 5 to 15 Years With Primary Nocturnal Enuresis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00245479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*